Federal Circuit’s Ruling Clears Path for Medivis’ Augmented Reality Innovation in Surgical Technology Dispute
Recently, Medivis Inc. successfully challenged some claims of a Novarad Corp. patent concerning augmented reality technology designed for surgical use. This development comes after the Federal Circuit criticized the Patent Trial and Appeal Board (PTAB) for its initial decision to uphold the entirety of the patent. On remand, the board concluded that Medivis had effectively…